Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Jun 02, 2023 12:48pm
290 Views
Post# 35477169

RE:RE:RE:RE:One detail that I just noticed

RE:RE:RE:RE:One detail that I just noticed

Eoganacht/Longholder99 ... Well stated.

Always interesting to hear from some that TLT management is incompetent when not a single big pharma was able to assemble a technology that could beat our treatment.  And it's TLT management that gave a chance to Prof. McFarland's molecule and allowed all its collaborators to go where no one went so far.

Nonody here has an avg. cost above let's say 0.40$.  Given where management brought us so far, despite all obstacles encountered and delays from COVID-19, I don't see why some still lack confidence in this management, especially if we get Breakthrough designation.  Valuation will take care of itself because market will react accordingly.  Trailblazers are never recognized in advanced.  Even the inventor of laparoscopy was kicked out of its Order of Medecine, only to be reintegrated 30y later!


_____________

 

RE:RE:RE:One detail that I just noticed
Last year management announced that BTD would be applied for by the end of 2022. We're 5 months into 2023 and they are still working on the submission.

I think it is very likely that second thoughts about the timing of the submission were based on communication with the FDA, the PI and the MSAB, along with the actual results that came in from the clinical trial sites. If, as Longholder99 writes, management decided to optimize our chances of achieving BTD and possibly AA by delaying the submission there is another way they can't win.

If they are more cautious about the claims they make in news releases they will be accused of being uncommunicative and will be advised by zealous posters to go out and hire a PR firm. If they go ahead and try to let shareholders know as much as they can they run the risk of being forced to backtrack on their projections for the good of the company and the good of shareholders themselves. And then they will be blamed for not living up to their promises!



Longholder99 wrote:Management can't win.  If they are meticulous and use consultation to ensure our chances at BTD and possibly AA....it's taking too long.  If they rushed and screwed up to please the children the masses would be running back to the OSC with another complaint. Watch and learn or sell your shares.   Jeeze
 

<< Previous
Bullboard Posts
Next >>